Telix Pharmaceuticals (TLX) Doses First Patient in Phase 3 Trial for Brain Cancer Therapy | Collector

Yahoo Finance

Telix Pharmaceuticals (TLX) Doses First Patient in Phase 3 Trial for Brain Cancer Therapy